Bionet Corp. operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bionet Corp. with three other
companies in this sector in Taiwan:
Syn-Tech Chem. & Pharm. Co., Ltd.
sales of 784.83 million Taiwanese Dollars [US$25.84 million]
of which 99%
was Sales revenue),
(822.37 million Taiwanese Dollars [US$27.07 million]
of which 100%
was Finished Products Sales), and
Abnova (Taiwan) Corporation
(426.02 million Taiwanese Dollars [US$14.02 million]
of which 27%
was Monoclonal Antibodies).
During the year ended December of 2018, sales at
Bionet Corp. were 770.61 million Taiwanese Dollars (US$25.37 million).
increase of 10.5%
versus 2017, when the company's sales were 697.40 million Taiwanese Dollars.
This was the third consecutive year of growth at Bionet Corp..